CoChat

Treatment of cognitive dysfunction in major depressive disorder—a review of the preclinical evidence for efficacy of selective serotonin reuptake inhibitors, serotonin–norepinephrine reuptake inhibitors and the multimodal-acting antidepressant vortioxetine

Open access
Pehrson, Alan L., Leiser, Steven C., Gulinello, Maria, Dale, Elena, Li, Yan, Waller, Jessica A., Sanchez, Connie · 2015 · European Journal of Pharmacology
Cited by 91

The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.

Abstract

Although major depressive disorder is primarily considered a mood disorder, depressed patients commonly present with clinically significant cognitive dysfunction that may add to their functional disability. This review paper summarizes the available preclinical data on the effects of antidepressants, including monoamine reuptake inhibitors and the multimodal antidepressant vortioxetine, in behavioral tests of cognition such as cognitive flexibility, attention, and memory, or in potentially cognition-relevant mechanistic assays such as electroencephalography, in vivo microdialysis, in vivo or in vitro electrophysiology, and molecular assays related to neurogenesis or synaptic sprouting. The available data are discussed in context with clinically relevant doses and their relationship to target occupancy levels, in order to evaluate the translational relevance of preclinical doses used during testing. We conclude that there is preclinical evidence suggesting that traditional treatment with monoamine reuptake inhibitors can induce improved cognitive function, for example in cognitive flexibility and memory, and that the multimodal-acting antidepressant vortioxetine may have some advantages by comparison to these treatments. However, the translational value of the reviewed preclinical data can be questioned at times, due to the use of doses outside the therapeutically-relevant range, the lack of data on target engagement or exposure, the tendency to investigate acute rather than long term antidepressant administration, and the trend towards using normal rodents rather than models with translational relevance for depression. Finally, several suggestions are made for advancing this field, including expanded use of target occupancy assessments in preclinical and clinical experiments, and the use of translationally valuable techniques such as electroencephalography.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.ejphar.2014.07.044

Cites

49 of 49 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 49 references

Research works printed but not linked: 141

  1. Alkam, 2011, Evaluation of object-based attention in mice, Behav. Brain Res., 220, 185, 10.1016/j.bbr.2011.01.039 · DOI
  2. Ashby, 1991, 5-HT3-like receptors in the rat medial prefrontal cortex: an electrophysiological study, Brain Res., 550, 181, 10.1016/0006-8993(91)91316-S · DOI
  3. Baarendse, 2012, Dissociable effects of monoamine reuptake inhibitors on distinct forms of impulsive behavior in rats, Psychopharmacology, 219, 313, 10.1007/s00213-011-2576-x · DOI · Paper page
  4. Barco, 2011, Genetic approaches to investigate the role of CREB in neuronal plasticity and memory, Mol. Neurobiol., 44, 330, 10.1007/s12035-011-8209-x · DOI
  5. Basar, 1999, Are cognitive processes manifested in event-related gamma, alpha, theta and delta oscillations in the EEG?, Neurosci. Lett., 259, 165, 10.1016/S0304-3940(98)00934-3 · DOI · Paper page
  6. Basar, 2000, Brain oscillations in perception and memory, Int. J. Psychophysiol., 35, 95, 10.1016/S0167-8760(99)00047-1 · DOI · Paper page
  7. Basar, 2001, Gamma, alpha, delta, and theta oscillations govern cognitive processes, Int. J. Psychophysiol., 39, 241, 10.1016/S0167-8760(00)00145-8 · DOI · Paper page
  8. Basar, 2008, A review of brain oscillations in cognitive disorders and the role of neurotransmitters, Brain Res., 1235, 172, 10.1016/j.brainres.2008.06.103 · DOI · Paper page
  9. Baune, 2006, The association between depressive mood and cognitive performance in an elderly general population—the MEMO Study, Dement. Geriatr. Cogn. Disord., 22, 142, 10.1159/000093745 · DOI · Paper page
  10. Beiko, 1997, The effect of nonspatial water maze pretraining in rats subjected to serotonin depletion and muscarinic receptor antagonism: a detailed behavioural assessment of spatial performance, Behav. Brain Res., 88, 201, 10.1016/S0166-4328(97)02298-5 · DOI
  11. Bell, 2003, Effects on sleep architecture of pindolol, paroxetine and their combination in healthy volunteers, Psychopharmacology, 166, 102, 10.1007/s00213-002-1314-9 · DOI
  12. Benavides-Piccione, 2013, Age-based comparison of human dendritic spine structure using complete three-dimensional reconstructions, Cereb. Cortex, 23, 1798, 10.1093/cercor/bhs154 · DOI · Paper page
  13. Betry, 2013, The rapid recovery of 5-HT cell firing induced by the antidepressant vortioxetine involves 5-HT(3) receptor antagonism, Int. J. Neuropsychopharmacol., 16, 1115, 10.1017/S1461145712001058 · DOI · Paper page
  14. Bianchi, 2009, Chronic fluoxetine differentially modulates the hippocampal microtubular and serotonergic system in grouped and isolation reared rats, Eur. Neuropsychopharmacol., 19, 778, 10.1016/j.euroneuro.2009.06.005 · DOI
  15. Biringer, 2005, The association between depression, anxiety, and cognitive function in the elderly general population—the Hordaland health study, Int. J. Geriatr. Psychiatry, 20, 989, 10.1002/gps.1390 · DOI · Paper page
  16. Bjorvatn, 1995, Sleep/waking and EEG power spectrum effects of a nonselective serotonin (5-HT) antagonist and a selective 5-HT reuptake inhibitor given alone and in combination, Sleep, 18, 451, 10.1093/sleep/18.6.451 · DOI
  17. Blokland, 2002, Anxiogenic and depressive-like effects, but no cognitive deficits, after repeated moderate tryptophan depletion in the rat, J. Psychopharmacol., 16, 39, 10.1177/026988110201600112 · DOI · Paper page
  18. Bondi, 2008, Chronic unpredictable stress induces a cognitive deficit and anxiety-like behavior in rats that is prevented by chronic antidepressant drug treatment, Neuropsychopharmacology, 33, 320, 10.1038/sj.npp.1301410 · DOI · Paper page
  19. Bordner, 2011, Parallel declines in cognition, motivation, and locomotion in aging mice: association with immune gene upregulation in the medial prefrontal cortex, Exp. Gerontol., 46, 643
  20. Carlini, 2007, Selective serotonin reuptake inhibitor (fluoxetine) decreases the effects of ghrelin on memory retention and food intake, Regul. Pept., 140, 65, 10.1016/j.regpep.2006.11.012 · DOI
  21. Carlini, 2012, Differential effects of fluoxetine and venlafaxine on memory recognition: possible mechanisms of action, Prog. Neuropsychopharmacol. Biol. Psychiatry, 38, 159, 10.1016/j.pnpbp.2012.03.004 · DOI · Paper page
  22. Chalon, 2005, Comparative effects of duloxetine and desipramine on sleep EEG in healthy subjects, Psychopharmacology, 177, 357, 10.1007/s00213-004-1961-0 · DOI
  23. Conrad, 2010, A critical review of chronic stress effects on spatial learning and memory, Prog. Neuropsychopharmacol. Biol. Psychiatry, 34, 742, 10.1016/j.pnpbp.2009.11.003 · DOI · Paper page
  24. Coppell, 2003, Bi-phasic change in BDNF gene expression following antidepressant drug treatment, Neuropharmacology, 44, 903, 10.1016/S0028-3908(03)00077-7 · DOI · Paper page
  25. Croarkin, 2011, Evidence for GABAergic inhibitory deficits in major depressive disorder, Neurosci. Biobehav. Rev., 35, 818, 10.1016/j.neubiorev.2010.10.002 · DOI
  26. Cuadra, 2001, Influence of different antidepressant drugs on the effect of chronic variable stress on restraint-induced dopamine release in frontal cortex, Neuropsychopharmacology, 25, 384, 10.1016/S0893-133X(01)00234-2 · DOI
  27. Cuadra, 1999, Chronic stress sensitizes frontal cortex dopamine release in response to a subsequent novel stressor: reversal by naloxone, Brain Res. Bull., 48, 303, 10.1016/S0361-9230(98)00179-8 · DOI · Paper page
  28. Dale, 2013, Vortioxetine (Lu AA21004) disinhibits pyramidal cell output and enhances theta rhythms and long-term plasticity in the hippocampus, Eur. Neuropsychopharmacol., 23, S394, 10.1016/S0924-977X(13)70622-9 · doi:10.1016/s0924-977x(13)70622-9
  29. David, 2009, Neurogenesis-dependent and -independent effects of fluoxetine in an animal model of anxiety/depression, Neuron, 62, 479, 10.1016/j.neuron.2009.04.017 · DOI · Paper page
  30. Dazzi, 2005, Chronic administration of the SSRI fluvoxamine markedly and selectively reduces the sensitivity of cortical serotonergic neurons to footshock stress, Eur. Neuropsychopharmacol., 15, 283, 10.1016/j.euroneuro.2004.11.003 · DOI
  31. Degroot, 2005, Fluoxetine disrupts the integration of anxiety and aversive memories, Neuropsychopharmacology, 30, 391, 10.1038/sj.npp.1300624 · DOI
  32. Delgado, 1990, Serotonin function and the mechanism of antidepressant action. Reversal of antidepressant-induced remission by rapid depletion of plasma tryptophan, Arch. Gen. Psychiatry, 47, 411, 10.1001/archpsyc.1990.01810170011002 · DOI · Paper page
  33. Denny, 2012, 4- to 6-week-old adult-born hippocampal neurons influence novelty-evoked exploration and contextual fear conditioning, Hippocampus, 22, 1188, 10.1002/hipo.20964 · DOI · Paper page
  34. Deschaux, 2011, Chronic treatment with fluoxetine prevents the return of extinguished auditory-cued conditioned fear, Psychopharmacology, 215, 231, 10.1007/s00213-010-2134-y · DOI
  35. de St Hilaire-Kafi, 1988, Hypnotic action of flunitrazepam in the rat: does 5-HT mechanism play a role?, Neuropharmacology, 27, 1227, 10.1016/0028-3908(88)90024-X · doi:10.1016/0028-3908(88)90024-x
  36. Di Chiara, 1999, Reciprocal changes in prefrontal and limbic dopamine responsiveness to aversive and rewarding stimuli after chronic mild stress: implications for the psychobiology of depression, Biol. Psychiatry, 46, 1624, 10.1016/S0006-3223(99)00236-X · DOI · Paper page
  37. Dincheva, 2012, Impact of the BDNF Val66Met polymorphism on cognition: implications for behavioral genetics, Neuroscientist, 18, 439, 10.1177/1073858411431646 · DOI · Paper page
  38. Dimpfel, 2003, Preclinical data base of pharmaco-specific rat EEG fingerprints (tele-stereo-EEG), Eur. J. Med. Res., 8, 199
  39. Dotson, 2009, Depressive symptoms and brain volumes in older adults: a longitudinal magnetic resonance imaging study, J. Psychiatry Neurosci., 34, 367, 10.1139/jpn.0948 · DOI · Paper page
  40. Drew, 2010, Arrest of adult hippocampal neurogenesis in mice impairs single- but not multiple-trial contextual fear conditioning, Behav. Neurosci., 124, 446, 10.1037/a0020081 · DOI · Paper page
  41. Dringenberg, 2000, Effect of tacrine on EEG slowing in the rat: enhancement by concurrent monoamine therapy, Neurobiol. Aging., 21, 135, 10.1016/S0197-4580(00)00108-1 · DOI
  42. Driscoll, 2006, The aging hippocampus: a multi-level analysis in the rat, Neuroscience, 139, 1173, 10.1016/j.neuroscience.2006.01.040 · DOI · Paper page
  43. du Jardin, 2013, Single dose vortioxetine or ketamine but not fluoxetine increases expression of neuroplasticity related genes in the rat prefrontal cortex, Eur. Neuropsychopharmacol., 23, S392, 10.1016/S0924-977X(13)70619-9 · DOI
  44. Elgersma, 2004, Mouse genetic approaches to investigating calcium/calmodulin-dependent protein kinase II function in plasticity and cognition, J. Neurosci., 24, 8410, 10.1523/JNEUROSCI.3622-04.2004 · DOI · Paper page
  45. Elizalde, 2008, Long-lasting behavioral effects and recognition memory deficit induced by chronic mild stress in mice: effect of antidepressant treatment, Psychopharmacology, 199, 1, 10.1007/s00213-007-1035-1 · DOI · Paper page
  46. El Hage, 2004, Impaired memory following predatory stress in mice is improved by fluoxetine, Prog. Neuropsychopharmacol Biol. Psychiatry, 28, 123, 10.1016/j.pnpbp.2003.09.028 · DOI · Paper page
  47. Eriksson, 2012, 5-HT1A and 5-HT7 receptor crosstalk in the regulation of emotional memory: implications for effects of selective serotonin reuptake inhibitors, Neuropharmacology, 63, 1150, 10.1016/j.neuropharm.2012.06.061 · DOI
  48. Feige, 2002, Fluoxetine and sleep EEG: effects of a single dose, subchronic treatment, and discontinuation in healthy subjects, Neuropsychopharmacology, 26, 246, 10.1016/S0893-133X(01)00314-1 · DOI
  49. Finlay, 1997, The effects of stress on central dopaminergic neurons: possible clinical implications, Neurochem. Res., 22, 1387, 10.1023/A:1022075324164 · DOI · Paper page
  50. Flood, 1987, Fluoxetine enhances memory processing in mice, Psychopharmacology, 93, 36, 10.1007/BF02439584 · DOI
  51. Gronier, 2003, Electrophysiological effects of acute and chronic olanzapine and fluoxetine in the rat prefrontal cortex, Neurosci. Lett., 349, 196, 10.1016/S0304-3940(03)00851-6 · DOI
  52. Grunbaum-Novak, 2008, Relationship between antidepressants and IGF-1 system in the brain: possible role in cognition, Eur. Neuropsychopharmacol., 18, 431, 10.1016/j.euroneuro.2007.08.004 · DOI
  53. Guilloux, 2013, Antidepressant and anxiolytic potential of the multimodal antidepressant vortioxetine (Lu AA21004) assessed by behavioural and neurogenesis outcomes in mice, Neuropharmacology, 73, 147, 10.1016/j.neuropharm.2013.05.014 · DOI · Paper page
  54. Gumuslu, 2013, The effects of tianeptine, olanzapine and fluoxetine on the cognitive behaviors of unpredictable chronic mild stress-exposed mice, Drug. Res., 63, 532, 10.1055/s-0033-1347237 · DOI
  55. Haddjeri, 2012, Effects of the multimodal antidepressant Lu AA21004 on rat synaptic and cellular hippocampal plasticity and memory recognition, Eur. Neuropsychopharmacol., 22, S303, 10.1016/S0924-977X(12)70462-5 · DOI
  56. Harvey, 2004, Serotonin and stress: protective or malevolent actions in the biobehavioral response to repeated trauma?, Ann. N. Y. Acad. Sci., 1032, 267, 10.1196/annals.1314.035 · DOI
  57. Hashimoto, 2007, Phencyclidine-induced cognitive deficits in mice are improved by subsequent subchronic administration of fluvoxamine: role of sigma-1 receptors, Neuropsychopharmacology, 32, 514, 10.1038/sj.npp.1301047 · DOI
  58. Holick, 2008, Behavioral effects of chronic fluoxetine in BALB/cJ mice do not require adult hippocampal neurogenesis or the serotonin 1A receptor, Neuropsychopharmacology, 33, 406, 10.1038/sj.npp.1301399 · DOI · Paper page
  59. Humpston, 2013, Investigating the roles of different monoamine transmitters and impulse control using the 5-choice serial reaction time task, J. Psychopharmacol., 27, 213, 10.1177/0269881112466182 · DOI
  60. Ibi, 2008, Social isolation rearing-induced impairment of the hippocampal neurogenesis is associated with deficits in spatial memory and emotion-related behaviors in juvenile mice, J. Neurochem., 105, 921, 10.1111/j.1471-4159.2007.05207.x · DOI · Paper page
  61. Ivarsson, 2005, Antidepressants and REM sleep in Wistar-Kyoto and Sprague-Dawley rats, Eur. J. Pharmacol., 522, 63, 10.1016/j.ejphar.2005.08.050 · DOI
  62. Jans, 2010, The effects of acute tryptophan depletion on affective behaviour and cognition in Brown Norway and Sprague Dawley rats, J. Psychopharmacol., 24, 605, 10.1177/0269881108099424 · DOI · Paper page
  63. Jansen, 1994, The effects of serotonergic drugs on short-term spatial memory in rats, J. Psychopharmacol., 8, 157, 10.1177/026988119400800303 · doi:10.1177/026988119400800303
  64. Jenkins, 2010, Effect of subchronic phencyclidine administration on sucrose preference and hippocampal parvalbumin immunoreactivity in the rat, Neurosci. Lett., 471, 144, 10.1016/j.neulet.2010.01.028 · DOI · Paper page
  65. Karpova, 2011, Fear erasure in mice requires synergy between antidepressant drugs and extinction training, Science, 334, 1731, 10.1126/science.1214592 · DOI · Paper page
  66. Katoh, 1995, Behavioral and electroencephalographic properties of duloxetine (LY248686), a reuptake inhibitor of norepinephrine and serotonin, in mice and rats, J. Pharmacol. Exp. Ther., 272, 1067, 10.1016/S0022-3565(25)24530-X · DOI
  67. Khawaja, 2004, Proteomic analysis of protein changes developing in rat hippocampus after chronic antidepressant treatment: implications for depressive disorders and future therapies, J. Neurosci. Res., 75, 451, 10.1002/jnr.10869 · DOI · Paper page
  68. Knott, 2002, EEG correlates of acute and chronic paroxetine treatment in depression, J. Affect Disord., 69, 241, 10.1016/S0165-0327(01)00308-1 · DOI
  69. Lader, 1986, The effects of citalopram in single and repeated doses and with alcohol on physiological and psychological measures in healthy subjects, Eur. J. Clin. Pharmacol., 31, 183, 10.1007/BF00606656 · DOI
  70. Lebron-Milad, 2013, Sex differences and estrous cycle in female rats interact with the effects of fluoxetine treatment on fear extinction, Behav. Brain Res., 253, 217, 10.1016/j.bbr.2013.07.024 · DOI
  71. Leiser, 2011, Aligning strategies for using EEG as a surrogate biomarker: a review of preclinical and clinical research, Biochem. Pharmacol., 81, 1408, 10.1016/j.bcp.2010.10.002 · DOI
  72. Leiser, 2014, The multimodal antidepressant vortioxetine increases frontal cortical oscillations unlike escitalopram and duloxetine—a quantitative electroencephalographic study in the rat, Br. J. Pharmacol., 10.1111/bph.12782 · DOI · Paper page
  73. Li, 2013, Memory impairment in old mice is differentially sensitive to different classes of antidepressants, Eur. Neuropsychopharmacol., 23, S282, 10.1016/S0924-977X(13)70440-1 · DOI
  74. Lieben, 2004, Acute tryptophan depletion induced by a gelatin-based mixture impairs object memory but not affective behavior and spatial learning in the rat, Behav. Brain Res., 151, 53, 10.1016/j.bbr.2003.08.002 · DOI
  75. Lindahl, 2004, Glutamate receptor subunits are altered in forebrain and cerebellum in rats chronically exposed to the NMDA receptor antagonist phencyclidine, Neuropsychopharmacology, 29, 2065, 10.1038/sj.npp.1300485 · DOI
  76. Linthorst, 2008, Stress and the brain: solving the puzzle using microdialysis, Pharmacol. Biochem. Behav., 90, 163, 10.1016/j.pbb.2007.09.019 · DOI
  77. Luthringer, 1996, A double-blind, placebo-controlled evaluation of the effects of orally administered venlafaxine on sleep in inpatients with major depression, Psychopharmacol Bull., 32, 637
  78. Malatynska, 2012, Anhedonic-like traits and lack of affective deficits in 18-month-old C57BL/6 mice: implications for modeling elderly depression, Exp. Gerontol., 47, 552, 10.1016/j.exger.2012.04.010 · DOI
  79. Martinez-Turrillas, 2005, Sequential changes in BDNF mRNA expression and synaptic levels of AMPA receptor subunits in rat hippocampus after chronic antidepressant treatment, Neuropharmacology, 49, 1178, 10.1016/j.neuropharm.2005.07.006 · DOI
  80. Martinez-Turrillas, 2002, Chronic antidepressant treatment increases the membrane expression of AMPA receptors in rat hippocampus, Neuropharmacology, 43, 1230, 10.1016/S0028-3908(02)00299-X · DOI
  81. Martisova, 2013, Effects of early maternal separation on biobehavioral and neuropathological markers of Alzheimer׳s disease in adult male rats, Curr. Alzheimer Res., 10, 420, 10.2174/1567205011310040007 · DOI
  82. Matsumoto, 2005, Chronic treatment with milnacipran reverses the impairment of synaptic plasticity induced by conditioned fear stress, Psychopharmacology, 179, 606, 10.1007/s00213-004-2094-1 · DOI
  83. McIntyre, 2013, Randomized, double-blind, placebo-controlled study of the efficacy of vortioxetine on cognitive dysfunction in adult patients with major depressive disorder (MDD), Neuropsychopharmacology, 38, 380
  84. Melo, 2012, Antidepressants differentially modify the extinction of an aversive memory task in female rats, Prog. Neuropsychopharmacol. Biol. Psychiatry, 37, 33, 10.1016/j.pnpbp.2012.01.012 · DOI
  85. Mnie-Filali, 2006, Allosteric modulation of the effects of the 5-HT reuptake inhibitor escitalopram on the rat hippocampal synaptic plasticity, Neurosci. Lett., 395, 23, 10.1016/j.neulet.2005.10.044 · DOI
  86. Montezinho, 2010, The effects of acute treatment with escitalopram on the different stages of contextual fear conditioning are reversed by atomoxetine, Psychopharmacology, 212, 131, 10.1007/s00213-010-1917-5 · DOI
  87. Mork, 2013, Vortioxetine (Lu AA21004), a novel multimodal antidepressant, enhances memory in rats, Pharmacol. Biochem. Behav., 105, 41, 10.1016/j.pbb.2013.01.019 · DOI · Paper page
  88. Neckelmann, 1996, Citalopram: differential sleep/wake and EEG power spectrum effects after single dose and chronic administration, Behav. Brain. Res., 79, 183, 10.1016/0166-4328(96)00013-7 · DOI
  89. Nibuya, 1996, Chronic antidepressant administration increases the expression of cAMP response element binding protein (CREB) in rat hippocampus, J. Neurosci., 16, 2365, 10.1523/JNEUROSCI.16-07-02365.1996 · DOI · Paper page
  90. Nicholson, 1986, 5-Hydroxytryptamine and noradrenaline uptake inhibition: studies on sleep in man, Neuropharmacology, 25, 1079, 10.1016/0028-3908(86)90153-X · DOI
  91. Nikiforuk, 2012, Selective blockade of 5-HT7 receptors facilitates attentional set-shifting in stressed and control rats, Behav. Brain Res., 226, 118, 10.1016/j.bbr.2011.09.006 · DOI
  92. Nikiforuk, 2013, Quetiapine ameliorates stress-induced cognitive inflexibility in rats, Neuropharmacology, 64, 357, 10.1016/j.neuropharm.2012.06.042 · DOI
  93. Nikiforuk, 2011, Long-lasting cognitive deficit induced by stress is alleviated by acute administration of antidepressants, Psychoneuroendocrinology, 36, 28, 10.1016/j.psyneuen.2010.06.001 · DOI
  94. Okamoto, 2010, Wnt2 expression and signaling is increased by different classes of antidepressant treatments, Biol. Psychiatry, 68, 521, 10.1016/j.biopsych.2010.04.023 · DOI · Paper page
  95. Pehrson, 2013, Vortioxetine, a novel multimodal antidepressant, modulates GABA and glutamate neurotransmission via serotonergic mechanisms, Eur. Neuropsychopharmacol., 23, S196, 10.1016/S0924-977X(13)70301-8 · DOI
  96. Pehrson, 2014, Serotonergic modulation of glutamate neurotransmission as a strategy for treating depression and cognitive dysfunction, CNS Spectr., 19, 121, 10.1017/S1092852913000540 · DOI · Paper page
  97. Popoli, 2002, Modulation of synaptic plasticity by stress and antidepressants, Bipolar Disord., 4, 166, 10.1034/j.1399-5618.2002.01159.x · DOI · Paper page
  98. Popoli, 1997, Long-term blockade of serotonin reuptake affects synaptotagmin phosphorylation in the hippocampus, Mol. Pharmacol., 51, 19, 10.1124/mol.51.1.19 · DOI
  99. Pratt, 2008, Modelling prefrontal cortex deficits in schizophrenia: implications for treatment, Br. J. Pharmacol., 153, S465
  100. Puig, 2010, Serotonin modulates fast-spiking interneuron and synchronous activity in the rat prefrontal cortex through 5-HT1A and 5-HT2A receptors, J. Neurosci., 30, 2211, 10.1523/JNEUROSCI.3335-09.2010 · DOI · Paper page
  101. Reppermund, 2011, The relationship of current depressive symptoms and past depression with cognitive impairment and instrumental activities of daily living in an elderly population: the Sydney memory and ageing study, J. Psychiatr. Res., 45, 1600, 10.1016/j.jpsychires.2011.08.001 · DOI · Paper page
  102. Richter-Levin, 1989, Spatial performance is severely impaired in rats with combined reduction of serotonergic and cholinergic transmission, Brain Res., 477, 404, 10.1016/0006-8993(89)91437-6 · DOI
  103. Riga, 2013, Role of 5-HT3 receptors in the mechanism of action of the investigational antidepressant vortioxetine, Eur. Neuropsychopharmacol., 23, S393, 10.1016/S0924-977X(13)70621-7 · DOI
  104. Ryan, 2009, Remodelling by early-life stress of NMDA receptor-dependent synaptic plasticity in a gene-environment rat model of depression, Int. J. Neuropsychopharmacol., 12, 553, 10.1017/S1461145708009607 · DOI · Paper page
  105. Saletu, 2010, EEG topography and tomography (LORETA) in diagnosis and pharmacotherapy of depression, Clin. EEG Neurosci., 41, 203, 10.1177/155005941004100407 · DOI · Paper page
  106. Saletu, 1985, Classification and determination of cerebral bioavailability of fluoxetine: pharmacokinetic, pharmaco-EEG, and psychometric analyses, J. Clin. Psychiatry, 46, 45
  107. Saletu, 1988, Drug profiling by computed electroencephalography and brain maps, with special consideration of sertraline and its psychometric effects, J Clin Psychi, 49, s59
  108. Saletu, 1992, Pharmacodynamics of venlafaxine evaluated by EEG brain mapping, psychometry and psychophysiology, Br. J. Clin. Pharmacol., 33, 589, 10.1111/j.1365-2125.1992.tb04087.x · DOI · Paper page
  109. Saletu, 1996, Comparative pharmacodynamic studies with the novel serotonin uptake-enhancing tianeptine and -inhibiting fluvoxamine utilizing EEG mapping and psychometry, J. Neural. Transm., 103, 191, 10.1007/BF01292627 · DOI
  110. Salin-Pascual, 1997, Effects of venlafaxine in the sleep architecture of rats, Psychopharmacology, 129, 295, 10.1007/s002130050194 · doi:10.1007/s002130050194
  111. Sanchez, 2007, Depression and poor sleep: the effect of monoaminergic antidepressants in a pre-clinical model in rats, Pharmacol. Biochem. Behav., 86, 468, 10.1016/j.pbb.2007.01.006 · DOI
  112. Santarelli, 2003, Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants, Science, 301, 805, 10.1126/science.1083328 · DOI · Paper page
  113. Schilstrom, 2011, Effects of S-citalopram, citalopram, and R-citalopram on the firing patterns of dopamine neurons in the ventral tegmental area, N-methyl-d-aspartate receptor-mediated transmission in the medial prefrontal cortex and cognitive function in the rat, Synapse, 65, 357, 10.1002/syn.20853 · DOI · Paper page
  114. Sebban, 1999, Changes in EEG spectral power in the prefrontal cortex of conscious rats elicited by drugs interacting with dopaminergic and noradrenergic transmission, Br. J. Pharmacol., 128, 1045, 10.1038/sj.bjp.0702894 · DOI · Paper page
  115. Seu, 2009, Effect of acute and repeated treatment with desipramine or methylphenidate on serial reversal learning in rats, Neuropharmacology, 57, 665, 10.1016/j.neuropharm.2009.08.007 · DOI · Paper page
  116. Seu, 2009, Inhibition of the norepinephrine transporter improves behavioral flexibility in rats and monkeys, Psychopharmacology, 202, 505, 10.1007/s00213-008-1250-4 · DOI · Paper page
  117. Siepmann, 2003, Effects of sertraline on autonomic and cognitive functions in healthy volunteers, Psychopharmacology, 168, 293, 10.1007/s00213-003-1448-4 · DOI
  118. Siepmann, 2008, The effects of venlafaxine on cognitive functions and quantitative EEG in healthy volunteers, Pharmacopsychiatry, 41, 146, 10.1055/s-2008-1076724 · DOI
  119. Song, 2006, Impairment of the spatial learning and memory induced by learned helplessness and chronic mild stress, Pharmacol. Biochem. Behav., 83, 186, 10.1016/j.pbb.2006.01.004 · DOI · Paper page
  120. Stancampiano, 1997, The decrease of serotonin release induced by a tryptophan-free amino acid diet does not affect spatial and passive avoidance learning, Brain Res., 762, 269, 10.1016/S0006-8993(97)00506-4 · DOI
  121. Staubli, 1994, Serotonin controls the magnitude of LTP induced by theta bursts via an action on NMDA-receptor-mediated responses, Brain Res., 643, 10, 10.1016/0006-8993(94)90003-5 · DOI
  122. Steffens, 2011, Change in hippocampal volume on magnetic resonance imaging and cognitive decline among older depressed and nondepressed subjects in the neurocognitive outcomes of depression in the elderly study, Am. J. Geriatr. Psychiatry, 19, 4, 10.1097/JGP.0b013e3181d6c245 · DOI · Paper page
  123. Stewart, 2000, Repeated ECS and fluoxetine administration have equivalent effects on hippocampal synaptic plasticity, Psychopharmacology, 148, 217, 10.1007/s002130050045 · DOI
  124. Tang, 1999, Genetic enhancement of learning and memory in mice, Nature, 401, 63, 10.1038/43432 · DOI · Paper page
  125. Tarn, 1993, Fluoxetine, amitriptyline and the electroencephalogram, J. Affect Disord., 29, 7, 10.1016/0165-0327(93)90112-W · DOI
  126. Thome, 2000, cAMP response element-mediated gene transcription is upregulated by chronic antidepressant treatment, J. Neurosci., 20, 4030, 10.1523/JNEUROSCI.20-11-04030.2000 · DOI · Paper page
  127. Tiraboschi, 2004, Selective phosphorylation of nuclear CREB by fluoxetine is linked to activation of CaM kinase IV and MAP kinase cascades, Neuropsychopharmacology, 29, 1831, 10.1038/sj.npp.1300488 · DOI · Paper page
  128. Topic, 2008, Extinction-induced "despair” in aged and adult rats: links to neurotrophins in frontal cortex and hippocampus, Neurobiol. Learn. Mem., 90, 519, 10.1016/j.nlm.2008.06.011 · DOI
  129. Torregrossa, 2012, Chronic corticosterone exposure during adolescence reduces impulsive action but increases impulsive choice and sensitivity to yohimbine in male Sprague-Dawley rats, Neuropsychopharmacology, 37, 1656, 10.1038/npp.2012.11 · DOI
  130. Vargas, 2014, In vivo activation of Wnt signaling pathway enhances cognitive function of adult mice and reverses cognitive deficits in an alzheimer׳s disease model, J. Neurosci., 34, 2191, 10.1523/JNEUROSCI.0862-13.2014 · DOI · Paper page
  131. Vila-Luna, 2012, Chronic caffeine consumption prevents cognitive decline from young to middle age in rats, and is associated with increased length, branching, and spine density of basal dendrites in CA1 hippocampal neurons, Neuroscience, 202, 384, 10.1016/j.neuroscience.2011.11.053 · DOI
  132. Vinkers, 2004, Temporal relation between depression and cognitive impairment in old age: prospective population based study, BMJ, 329, 881, 10.1136/bmj.38216.604664.DE · DOI · Paper page
  133. Valluzzi, 2007, Effects of fluoxetine on hippocampal-dependent and hippocampal-independent learning tasks, Behav. Pharmacol., 18, 507, 10.1097/FBP.0b013e3282ee2a91 · DOI · Paper page
  134. Vas, 2013, Differential adaptation of REM sleep latency, intermediate stage and theta power effects of escitalopram after chronic treatment, J. Neural. Transm., 120, 169, 10.1007/s00702-012-0847-2 · DOI
  135. von Engelhardt, 2008, Contribution of hippocampal and extra-hippocampal NR2B-containing NMDA receptors to performance on spatial learning tasks, Neuron, 60, 846, 10.1016/j.neuron.2008.09.039 · DOI · Paper page
  136. Ward, 2003, Synchronous neural oscillations and cognitive processes, Trends Cogn. Sci., 7, 553, 10.1016/j.tics.2003.10.012 · DOI · Paper page
  137. Westrich, 2012, In vitro and in vivo effects of the multimodal antidepressant vortioxetine (Lu AA21004) at human and rat targets, Int. J. Psychiatry Clin. Pract., 5, 47
  138. Wilson, 2004, Using sleep to evaluate comparative serotonergic effects of paroxetine and citalopram, Eur. Neuropsychopharmacol., 14, 367, 10.1016/j.euroneuro.2003.11.004 · DOI
  139. Yau, 2002, Chronic treatment with the antidepressant amitriptyline prevents impairments in water maze learning in aging rats, J. Neurosci., 22, 1436, 10.1523/JNEUROSCI.22-04-01436.2002 · DOI · Paper page
  140. Zhong, 2011, Differential regulation of the excitability of prefrontal cortical fast-spiking interneurons and pyramidal neurons by serotonin and fluoxetine, PloS One, 6, e16970, 10.1371/journal.pone.0016970 · DOI · Paper page
  141. Zhou, 1999, Activation of serotonin receptors modulates synaptic transmission in rat cerebral cortex, J. Neurophysiol., 82, 2989, 10.1152/jn.1999.82.6.2989 · DOI · Paper page

Cited by

See all 91

Metadata

Authors
Pehrson, A. L., Leiser, S. C., Gulinello, M., Dale, E., Li, Y., Waller, J. A., & Sanchez, C.
Venue
European Journal of Pharmacology
Publisher
Elsevier BV
Published
2015-04
Volume
753
Pages
19-31
ISSN
0014-2999 (ISSN-L)
OpenAlex
W1969903815
Cited by
91
References
49
FWCI
7.58
Type
journal article
Language
en
Open access
hybrid
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Treatment of cognitive dysfunction in major depressive disorder—a review of the preclinical evidence for efficacy of selective serotonin reuptake inhibitors, serotonin–norepinephrine reuptake inhibitors and the multimodal-acting antidepressant vortioxetine. https://app.cochat.ai/papers/10.1016/j.ejphar.2014.07.044
The paper
Pehrson, A. L., Leiser, S. C., Gulinello, M., Dale, E., Li, Y., Waller, J. A., & Sanchez, C. (2015). Treatment of cognitive dysfunction in major depressive disorder—a review of the preclinical evidence for efficacy of selective serotonin reuptake inhibitors, serotonin–norepinephrine reuptake inhibitors and the multimodal-acting antidepressant vortioxetine. European Journal of Pharmacology. https://doi.org/10.1016/j.ejphar.2014.07.044

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.